Skip to content
KCCR-AM
    • Homepage
Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangitis (PBC) Granted Priority Review by the US FDA

Author: Klick Inc.

Posted Date:

May 28, 2026
  • Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangitis (PBC) Granted Priority Review by the US FDA

    Klick Inc.
    May 28, 2026